PRESS RELEASES
2011-10-20
Les espoirs de la médecine personnalisée
read more »
MEMBER LOGIN
NEWSLETTER
Subscribe to our newsletter:
WELCOME
WIN Consortium offers an opportunity to make an impact on personalized cancer therapy across the globe by increasing the number of patients having access to innovative clinical trials and treatment with the latest innovative drugs.
John Mendelsohn, Chairman of the WIN Consortium
2011 WIN SYMPOSIUM
Interview Alexander Eggermont
Member of the WIN Consortium Directorate and Director of Insitut Gustave Roussy (France)
